1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Peritoneal Dialysis Market, by Product
7.1.1. Peritoneal Dialysis Machines (Cyclers)
7.1.1.1. Market Revenue and Forecast
7.1.2. Peritoneal Dialysis Solutions
7.1.2.1. Market Revenue and Forecast
7.1.3. Peritoneal Dialysis Catheters
7.1.3.1. Market Revenue and Forecast
7.1.4. Transfer Sets
7.1.4.1. Market Revenue and Forecast
7.1.5. Disinfection & Accessories
7.1.5.1. Market Revenue and Forecast
8.1. Peritoneal Dialysis Market, by Dialysis Type
8.1.1. Continuous Ambulatory Peritoneal Dialysis (CAPD)
8.1.1.1. Market Revenue and Forecast
8.1.2. Automated Peritoneal Dialysis (APD)
8.1.2.1. Market Revenue and Forecast
9.1. Peritoneal Dialysis Market, by Treatment Setting
9.1.1. Home-based Peritoneal Dialysis
9.1.1.1. Market Revenue and Forecast
9.1.2. Hospital-based Peritoneal Dialysis
9.1.2.1. Market Revenue and Forecast
9.1.3. Dialysis Centers
9.1.3.1. Market Revenue and Forecast
10.1. Peritoneal Dialysis Market, by Indication
10.1.1. Acute Kidney Injury (AKI)
10.1.1.1. Market Revenue and Forecast
10.1.2. Chronic Kidney Disease (CKD)
10.1.2.1. Market Revenue and Forecast
10.1.3. End-Stage Renal Disease (ESRD)
10.1.3.1. Market Revenue and Forecast
11.1. Peritoneal Dialysis Market, by Age Group
11.1.1. Pediatric
11.1.1.1. Market Revenue and Forecast
11.1.2. Adult
11.1.2.1. Market Revenue and Forecast
11.1.3. Geriatric
11.1.3.1. Market Revenue and Forecast
12.1. Peritoneal Dialysis Market, by End User
12.1.1. Home Care
12.1.1.1. Market Revenue and Forecast
12.1.2. Hospitals
12.1.2.1. Market Revenue and Forecast
12.1.3. Dialysis Centers
12.1.3.1. Market Revenue and Forecast
12.1.4. Ambulatory Surgical Centers
12.1.4.1. Market Revenue and Forecast
12.1.5. Specialty Clinics
12.1.5.1. Market Revenue and Forecast
13.1. Peritoneal Dialysis Market, by Distribution Channel
13.1.1. Direct Sales
13.1.1.1. Market Revenue and Forecast
13.1.2. Hospital Pharmacies
13.1.2.1. Market Revenue and Forecast
13.1.3. Retail Pharmacies
13.1.3.1. Market Revenue and Forecast
13.1.4. Online Pharmacies
13.1.4.1. Market Revenue and Forecast
13.1.5. Medical Distributors
13.1.5.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product
14.1.2. Market Revenue and Forecast, by Dialysis Type
14.1.3. Market Revenue and Forecast, by Treatment Setting
14.1.4. Market Revenue and Forecast, by Indication
14.1.5. Market Revenue and Forecast, by Age Group
14.1.6. Market Revenue and Forecast, by Distribution Channel
14.1.7. Market Revenue and Forecast, by End User
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product
14.1.8.2. Market Revenue and Forecast, by Dialysis Type
14.1.8.3. Market Revenue and Forecast, by Treatment Setting
14.1.8.4. Market Revenue and Forecast, by Indication
14.1.8.5. Market Revenue and Forecast, by Age Group
14.1.8.6. Market Revenue and Forecast, by Distribution Channel
14.1.8.7. Market Revenue and Forecast, by End User
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product
14.1.9.2. Market Revenue and Forecast, by Dialysis Type
14.1.9.3. Market Revenue and Forecast, by Treatment Setting
14.1.9.4. Market Revenue and Forecast, by Indication
14.1.9.5. Market Revenue and Forecast, by Age Group
14.1.9.6. Market Revenue and Forecast, by Distribution Channel
14.1.9.7. Market Revenue and Forecast, by End User
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product
14.2.2. Market Revenue and Forecast, by Dialysis Type
14.2.3. Market Revenue and Forecast, by Treatment Setting
14.2.4. Market Revenue and Forecast, by Indication
14.2.5. Market Revenue and Forecast, by Age Group
14.2.6. Market Revenue and Forecast, by Distribution Channel
14.2.7. Market Revenue and Forecast, by End User
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product
14.2.8.2. Market Revenue and Forecast, by Dialysis Type
14.2.8.3. Market Revenue and Forecast, by Treatment Setting
14.2.8.4. Market Revenue and Forecast, by Indication
14.2.8.5. Market Revenue and Forecast, by Age Group
14.2.8.6. Market Revenue and Forecast, by Distribution Channel
14.2.8.7. Market Revenue and Forecast, by End User
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product
14.2.9.2. Market Revenue and Forecast, by Dialysis Type
14.2.9.3. Market Revenue and Forecast, by Treatment Setting
14.2.9.4. Market Revenue and Forecast, by Indication
14.2.9.5. Market Revenue and Forecast, by Age Group
14.2.9.6. Market Revenue and Forecast, by Distribution Channel
14.2.9.7. Market Revenue and Forecast, by End User
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product
14.2.10.2. Market Revenue and Forecast, by Dialysis Type
14.2.10.3. Market Revenue and Forecast, by Treatment Setting
14.2.10.4. Market Revenue and Forecast, by Indication
14.2.10.5. Market Revenue and Forecast, by Age Group
14.2.10.6. Market Revenue and Forecast, by Distribution Channel
14.2.10.7. Market Revenue and Forecast, by End User
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product
14.2.11.2. Market Revenue and Forecast, by Dialysis Type
14.2.11.3. Market Revenue and Forecast, by Treatment Setting
14.2.11.4. Market Revenue and Forecast, by Indication
14.2.11.5. Market Revenue and Forecast, by Age Group
14.2.11.6. Market Revenue and Forecast, by Distribution Channel
14.2.11.7. Market Revenue and Forecast, by End User
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product
14.3.2. Market Revenue and Forecast, by Dialysis Type
14.3.3. Market Revenue and Forecast, by Treatment Setting
14.3.4. Market Revenue and Forecast, by Indication
14.3.5. Market Revenue and Forecast, by Age Group
14.3.6. Market Revenue and Forecast, by Distribution Channel
14.3.7. Market Revenue and Forecast, by End User
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product
14.3.8.2. Market Revenue and Forecast, by Dialysis Type
14.3.8.3. Market Revenue and Forecast, by Treatment Setting
14.3.8.4. Market Revenue and Forecast, by Indication
14.3.8.5. Market Revenue and Forecast, by Age Group
14.3.8.6. Market Revenue and Forecast, by Distribution Channel
14.3.8.7. Market Revenue and Forecast, by End User
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product
14.3.9.2. Market Revenue and Forecast, by Dialysis Type
14.3.9.3. Market Revenue and Forecast, by Treatment Setting
14.3.9.4. Market Revenue and Forecast, by Indication
14.3.9.5. Market Revenue and Forecast, by Age Group
14.3.9.6. Market Revenue and Forecast, by Distribution Channel
14.3.9.7. Market Revenue and Forecast, by End User
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product
14.3.10.2. Market Revenue and Forecast, by Dialysis Type
14.3.10.3. Market Revenue and Forecast, by Treatment Setting
14.3.10.4. Market Revenue and Forecast, by Indication
14.3.10.5. Market Revenue and Forecast, by Age Group
14.3.10.6. Market Revenue and Forecast, by Distribution Channel
14.3.10.7. Market Revenue and Forecast, by End User
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product
14.3.11.2. Market Revenue and Forecast, by Dialysis Type
14.3.11.3. Market Revenue and Forecast, by Treatment Setting
14.3.11.4. Market Revenue and Forecast, by Indication
14.3.11.5. Market Revenue and Forecast, by Age Group
14.3.11.6. Market Revenue and Forecast, by Distribution Channel
14.3.11.7. Market Revenue and Forecast, by End User
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product
14.4.2. Market Revenue and Forecast, by Dialysis Type
14.4.3. Market Revenue and Forecast, by Treatment Setting
14.4.4. Market Revenue and Forecast, by Indication
14.4.5. Market Revenue and Forecast, by Age Group
14.4.6. Market Revenue and Forecast, by Distribution Channel
14.4.7. Market Revenue and Forecast, by End User
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product
14.4.8.2. Market Revenue and Forecast, by Dialysis Type
14.4.8.3. Market Revenue and Forecast, by Treatment Setting
14.4.8.4. Market Revenue and Forecast, by Indication
14.4.8.5. Market Revenue and Forecast, by Age Group
14.4.8.6. Market Revenue and Forecast, by Distribution Channel
14.4.8.7. Market Revenue and Forecast, by End User
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product
14.4.9.2. Market Revenue and Forecast, by Dialysis Type
14.4.9.3. Market Revenue and Forecast, by Treatment Setting
14.4.9.4. Market Revenue and Forecast, by Indication
14.4.9.5. Market Revenue and Forecast, by Age Group
14.4.9.6. Market Revenue and Forecast, by Distribution Channel
14.4.9.7. Market Revenue and Forecast, by End User
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product
14.4.10.2. Market Revenue and Forecast, by Dialysis Type
14.4.10.3. Market Revenue and Forecast, by Treatment Setting
14.4.10.4. Market Revenue and Forecast, by Indication
14.4.10.5. Market Revenue and Forecast, by Age Group
14.4.10.6. Market Revenue and Forecast, by Distribution Channel
14.4.10.7. Market Revenue and Forecast, by End User
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product
14.4.11.2. Market Revenue and Forecast, by Dialysis Type
14.4.11.3. Market Revenue and Forecast, by Treatment Setting
14.4.11.4. Market Revenue and Forecast, by Indication
14.4.11.5. Market Revenue and Forecast, by Age Group
14.4.11.6. Market Revenue and Forecast, by Distribution Channel
14.4.11.7. Market Revenue and Forecast, by End User
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product
14.5.2. Market Revenue and Forecast, by Dialysis Type
14.5.3. Market Revenue and Forecast, by Treatment Setting
14.5.4. Market Revenue and Forecast, by Indication
14.5.5. Market Revenue and Forecast, by Age Group
14.5.6. Market Revenue and Forecast, by Distribution Channel
14.5.7. Market Revenue and Forecast, by End User
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product
14.5.8.2. Market Revenue and Forecast, by Dialysis Type
14.5.8.3. Market Revenue and Forecast, by Treatment Setting
14.5.8.4. Market Revenue and Forecast, by Indication
14.5.8.5. Market Revenue and Forecast, by Age Group
14.5.8.6. Market Revenue and Forecast, by Distribution Channel
14.5.8.7. Market Revenue and Forecast, by End User
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product
14.5.9.2. Market Revenue and Forecast, by Dialysis Type
14.5.9.3. Market Revenue and Forecast, by Treatment Setting
14.5.9.4. Market Revenue and Forecast, by Indication
14.5.9.5. Market Revenue and Forecast, by Age Group
14.5.9.6. Market Revenue and Forecast, by Distribution Channel
14.5.9.7. Market Revenue and Forecast, by End User
15.1. Vantive Health LLC
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Fresenius Medical Care AG & Co. KGaA
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Medtronic plc
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. JMS Co., Ltd.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Abbott
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Abbott
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Abbott
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Abbott
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Abbott
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Abbott
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client